How to say NO to vascular disruption and stem cell mobilization

References

• Passaro D, Di Tullio A, Abarrategi A, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017 Sep 11;32(3):324–341 e6. PubMed PMID: 28870739; PubMed Central PMCID: PMCPMC5598545.
   PubMed Web of Science ®Google Scholar
• Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11–17;327(6122):524–526.. PubMed PMID: 3495737.
   PubMed Web of Science ®Google Scholar
• Hatakeyama T, Pappas PJ, Hobson RW 2nd, et al. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol. 2006 Jul 1;574(Pt 1):275–281. PubMed PMID: 16675496; PubMed Central PMCID: PMCPMC1817804.
   PubMed Web of Science ®Google Scholar
• Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003 Dec;4(4):53–60. PubMed PMID: 14664903.
   PubMed Web of Science ®Google Scholar
• Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001 Feb 27 98(5):2604–2609. PubMed PMID: 11226286; PubMed Central PMCID: PMCPMC30185
   PubMed Web of Science ®Google Scholar
• McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002 Sep 15;62(18):5381–5385. PubMed PMID: 12235011.
   PubMed Web of Science ®Google Scholar
• Cogle CR, Bosse RC, Brewer T, et al. Acute myeloid leukemia in the vascular niche. Cancer Lett. 2016 Oct 1;380(2):552–560. PubMed PMID: 25963886.
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003 Nov;9(11):1370–1376. PubMed PMID: 14556003.
   PubMed Web of Science ®Google Scholar
• Chigaev A, Smagley Y, Sklar LA. Nitric oxide/cGMP pathway signaling actively down-regulates alpha4beta1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion. BMC Immunol. 2011 May 17;12:28.
   PubMed Web of Science ®Google Scholar
• Foster K, Lassailly F, Anjos-Afonso F, et al. Different motile behaviors of human hematopoietic stem versus progenitor cells at the osteoblastic niche. Stem Cell Reports. 2015 Nov 10;5(5):690–701. PubMed PMID: 26455414.
   PubMed Web of Science ®Google Scholar
• Rafii S, Mohle R, Shapiro F, et al. Regulation of hematopoiesis by microvascular endothelium. Leukemia & Lymphoma. 1997 Nov;27(5–6):375–386. PubMed PMID: 9477120.
   PubMed Web of Science ®Google Scholar
• Itkin T, Gur-Cohen S, Ja S, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016 Apr 21;532(7599):323–328. PubMed PMID: 27074509.
   PubMed Web of Science ®Google Scholar
• Singh P, Hoggatt J, Kamocka MM, et al. Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. J Clin Invest. 2017 Nov 13;127:4527–4540. PubMed PMID: 29130940.
   PubMed Web of Science ®Google Scholar
• Vitecek J, Lojek A, Valacchi G, et al. Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges. Mediators Inflamm. 2012;2012:318087. PubMed PMID: 22988346; PubMed Central PMCID: PMCPMC3441039.
   PubMedGoogle Scholar
• Gratton JP, Lin MI, Yu J, et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell. 2003 Jul;4(1):31–39. PubMed PMID: 12892711.
   PubMed Web of Science ®Google Scholar
• Meadows KL, Hurwitz HI. Anti-VEGF therapies in the clinic. Cold Spring Harb Perspect Med. 2012 Oct 1;2(10). PubMed PMID: 23028128; PubMed Central PMCID: PMCPMC3475399. Doi: 10.1101/cshperspect.a006577.
   PubMed Web of Science ®Google Scholar
• Gordon EM, Figueroa DM, Barochia AV, et al. High-density Lipoproteins and Apolipoprotein A-I: potential new players in the prevention and treatment of lung disease. Front Pharmacol. 2016;7:519. PubMed PMID: 28111549; PubMed Central PMCID: PMCPMC5216034.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Rusnati M, et al. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3–4):327–334. PubMed PMID: 17537668.
   PubMed Web of Science ®Google Scholar
• Aref S, Mabed M, Sakrana S, et al. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics. Hematology. 2002 Oct;7(5):273–279. PubMed PMID: 12850814.
   PubMedGoogle Scholar
• Fantin A, Lampropoulou A, Senatore V, et al. VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation. J Exp Med. 2017 Apr 3;214(4):1049–1064. PubMed PMID: 28289053; PubMed Central PMCID: PMCPMC5379968.
   PubMed Web of Science ®Google Scholar
• Erskine L, Francois U, Denti L, et al. VEGF-A and neuropilin 1 (NRP1) shape axon projections in the developing CNS via dual roles in neurons and blood vessels. Development. 2017 Jul 1;144(13):2504–2516. PubMed PMID: 28676569; PubMed Central PMCID: PMCPMC5536872.
   PubMed Web of Science ®Google Scholar
• Craige SM, Chen K, Pei Y, et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation. 2011 Aug 9;124(6):731–740. PubMed PMID: 21788590; PubMed Central PMCID: PMCPMC3589548.
   PubMed Web of Science ®Google Scholar
• Altenhofer S, Radermacher KA, Kleikers PW, et al. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal. 2015 Aug 10;23(5):406–427. PubMed PMID: 24383718; PubMed Central PMCID: PMCPMC4543484.
   PubMed Web of Science ®Google Scholar
• Tillery LC, Epperson TA, Eguchi S, et al. Featured Article: differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells. Exp Biol Med (Maywood). 2016 Mar;241(6):569–580. PubMed PMID: 26729042; PubMed Central PMCID: PMCPMC4950326.
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R, De Ceunynck K. Targeting PAR1: now what? Trends Pharmacol Sci. 2017 Aug;38(8):701–716.. PubMed PMID: 28558960; PubMed Central PMCID: PMCPMC5580498.
   PubMed Web of Science ®Google Scholar